NUR 6400 Module 1 Cellular Injury Case: Iron Overload in HFE Hemochromatosis Example

A Gene That Lowers One Hormone: Iron, Oxidant Injury and Liver Fibrosis in a 52-Year-Old Man With HFE Hemochromatosis

Student Name

Master of Science in Nursing, Thomas Edison State University

NUR-6400: Advanced Pathophysiology

Mentor Name

Month Day, Year

A Gene That Lowers One Hormone: Iron, Oxidant Injury and Liver Fibrosis in a 52-Year-Old Man With HFE Hemochromatosis

Introduction

Mr. K. is a composite patient, a 52-year-old electrician of Irish descent who saw his primary care provider for tiredness and stiff knuckles. His alanine aminotransferase was 88 units per liter, his transferrin saturation 71 percent and his serum ferritin 1,460 nanograms per milliliter. A gene panel showed two copies of C282Y, one inherited from each parent. He drinks about four beers most evenings. This paper explains his illness as a chain of events that begins with one altered protein and ends with injured liver cells, and it shows where his sex and his drinking change the course of that chain.

Etiology: A Hormone That Fails to Rise

Iron has no regulated exit from the body. Small amounts leave with shed skin and gut cells, so balance is kept almost entirely at the point of absorption. The liver controls that point with hepcidin, a small peptide hormone that binds ferroportin, the only known iron exporter on duodenal enterocytes and macrophages, and causes it to be internalized and broken down. When iron stores rise, the liver should make more hepcidin, ferroportin should fall, and absorption should slow.

The HFE protein is part of the sensing system that tells hepatocytes how much iron is circulating. The C282Y substitution prevents HFE from folding correctly and reaching the cell surface, so the liver reads the body as iron poor no matter how full it is. Pietrangelo (2010) describes inappropriately low hepcidin as the shared defect behind the hereditary forms of the disease. In Mr. K., ferroportin stayed on the enterocyte surface for decades, and his gut kept absorbing a few milligrams more than he lost each day.

Epidemiology and Penetrance

C282Y homozygosity is common among people of northern European ancestry, about one in every 200 to 300 in that group (Kowdley et al., 2019), yet most homozygous people never develop disease. Allen et al. (2008) followed a large Australian cohort and found documented iron overload disease in 28.4 percent of homozygous men and in only 1.2 percent of homozygous women. A genotype that harms fewer than a third of the men who carry it is said to have low and variable penetrance, and that variability is where lifestyle and sex enter the explanation.

Cellular Adaptation Before Injury

Iron that enters the hepatocyte is first handled safely. Cells raise their production of ferritin, a hollow protein shell that holds thousands of iron atoms in a nonreactive form, and they condense older ferritin into hemosiderin inside lysosomes. This is adaptation in the strict sense: the cell changes its contents to survive a sustained load without losing function. For years Mr. K.'s liver did exactly that, and his transferrin saturation rose without symptoms.

Adaptation has a ceiling. Once storage capacity is exceeded, a pool of loosely bound iron accumulates in the cytoplasm. Ferrous iron reacts with hydrogen peroxide produced by normal mitochondrial respiration and yields the hydroxyl radical, one of the most reactive molecules in biology. Hydroxyl radicals attack the double bonds of membrane lipids, starting chain reactions of lipid peroxidation that damage the plasma membrane, mitochondria and lysosomes. When iron-laden lysosomes leak, they release more iron and digestive enzymes into the cytoplasm, and the injury spreads.

From Injured Hepatocyte to Fibrosis

Injured hepatocytes release signals that activate hepatic stellate cells, which normally store vitamin A in the space between hepatocytes and the sinusoid. Once activated, stellate cells become collagen-producing myofibroblasts. Repeated cycles of hepatocyte injury and stellate cell activation lay down scar tissue that slowly distorts the lobule, and the end of that process is cirrhosis with its risk of hepatocellular carcinoma. Kowdley et al. (2019) note that a ferritin above 1,000 nanograms per milliliter with raised aminotransferases signals a higher likelihood of advanced fibrosis, which is why Mr. K.'s results call for staging of his liver disease before treatment begins.

Clinical Presentation Explained

Each of Mr. K.'s findings fits a step in the chain. His raised transferrin saturation is the earliest sign, reflecting more iron entering plasma than the transport protein can comfortably carry. His high ferritin reflects the expanded storage pool. His raised alanine aminotransferase is the enzyme leaking from injured hepatocyte membranes. His stiff second and third knuckles reflect an arthropathy in which iron deposits in joint tissue, a pattern typical enough of hemochromatosis that it often prompts the first test. Fatigue is the least specific symptom and may reflect early liver dysfunction, endocrine effects of iron in the pancreas and pituitary, or both.

Predisposing Factors: Sex, Alcohol and Epigenetics

Sex is the strongest modifier in the cohort data. Menstruation and pregnancy remove iron that men never lose, so women carrying the same genotype reach toxic stores later or not at all, and this explains much of the gap that Allen et al. (2008) reported. Alcohol pushes in the other direction. Ethanol itself suppresses hepcidin, adding to the genetic defect, and it injures hepatocytes and activates stellate cells through its own oxidant pathways, so the two injuries converge on the same cells. Mr. K.'s nightly drinking is therefore not a separate risk factor listed at the end but a second push on the same steps of the chain.

Epigenetic and metabolic influences may explain part of the remaining variation. Hepcidin expression is set by signaling pathways and chromatin states that are sensitive to inflammation, obesity and alcohol, and fatty liver disease adds its own oxidant load. These effects are less settled than the role of sex, so they are better presented as plausible contributors than as proven causes.

Conclusion

Mr. K.'s disease began with a protein that could not tell his liver how much iron he held. Low hepcidin allowed decades of excess absorption, hepatocytes adapted by storing iron until their capacity ran out, and free iron then drove oxidant injury, stellate cell activation and fibrosis. His sex removed the protection women carry, and his drinking added a second injury to the same cells. Removing iron by phlebotomy and stopping alcohol act on the same chain, which is why understanding the mechanism comes before the treatment plan.

References

Allen, K. J., Gurrin, L. C., Constantine, C. C., Osborne, N. J., Delatycki, M. B., Nicoll, A. J., McLaren, C. E., Bahlo, M., Nisselle, A. E., Vulpe, C. D., Anderson, G. J., Southey, M. C., Giles, G. G., English, D. R., Hopper, J. L., Olynyk, J. K., Powell, L. W., & Gertig, D. M. (2008). Iron-overload-related disease in HFE hereditary hemochromatosis. New England Journal of Medicine, 358(3), 221-230. https://doi.org/10.1056/NEJMoa073286

Kowdley, K. V., Brown, K. E., Ahn, J., & Sundaram, V. (2019). ACG clinical guideline: Hereditary hemochromatosis. American Journal of Gastroenterology, 114(8), 1202-1218. https://doi.org/10.14309/ajg.0000000000000315

Pietrangelo, A. (2010). Hereditary hemochromatosis: Pathogenesis, diagnosis, and treatment. Gastroenterology, 139(2), 393-408. https://doi.org/10.1053/j.gastro.2010.06.013